GlucoTrack
GCTK
3 hedge funds and large institutions have $68.9K invested in GlucoTrack in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
7% less capital invested
Capital invested by funds: $74K → $68.9K (-$5.08K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boston Financial Management
Boston,
Massachusetts
| $37.2K | – | – | – |
|
|
AF
2
Alerus Financial
Grand Forks,
North Dakota
| $16.2K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $15.5K | +$20.5K | +2 | New |
|
GCTK Hedge Fund Activity: Q4 2022 in Review
3 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q4 2022, worth a combined $68.9K — down 6.9% from $74K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GCTK positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $20.5K.
- 3 institutional investors held GlucoTrack (GCTK) as of Q4 2022, up from 2 in Q3 2022.
- Funds reported $68.9K of GlucoTrack stock for Q4 2022, down 6.9% quarter-over-quarter.
- 1 fund opened new GlucoTrack positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest GlucoTrack buyer in Q4 2022 was Susquehanna International Group, an estimated $20.5K added.
Based on aggregated 13F filings for Q4 2022.